What does a high Triglyceride to HDL ratio mean?

A high triglyceride to HDL ratio indicates increased cardiovascular disease risk and metabolic dysfunction. Ratios above 2.0 suggest insulin resistance, while optimal levels are below 1.0, with lifestyle changes and regular monitoring helping improve this important health marker.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Triglyceride to HDL Ratio

The triglyceride to HDL cholesterol ratio is one of the most powerful predictors of cardiovascular disease risk and metabolic health. This simple calculation provides valuable insights into your body's ability to process fats and sugars, offering a window into your overall metabolic function. Unlike traditional cholesterol tests that focus solely on LDL levels, this ratio helps identify insulin resistance and metabolic syndrome even before other symptoms appear.

To calculate your ratio, simply divide your triglyceride level by your HDL cholesterol level. For example, if your triglycerides are 150 mg/dL and your HDL is 50 mg/dL, your ratio would be 3.0. This number carries significant meaning for your health, as research shows it correlates strongly with insulin resistance, inflammation, and the presence of small, dense LDL particles that are particularly harmful to your arteries.

What Your Ratio Numbers Mean

Understanding where your triglyceride to HDL ratio falls on the spectrum is crucial for assessing your cardiovascular and metabolic health. The medical community has established clear guidelines for interpreting these values, though optimal ranges may vary slightly based on individual factors and overall health status.

Triglyceride to HDL Ratio Risk Categories

Risk categories based on clinical research. Individual risk may vary based on other health factors.
Ratio RangeRisk CategoryHealth ImplicationsRecommended Actions
Below 1.0< 1.0OptimalExcellent metabolic health, low cardiovascular riskMaintain healthy lifestyle
1.0-2.01.0-2.0AcceptableGood metabolic health, slightly elevated riskMinor lifestyle adjustments
2.1-3.02.1-3.0Borderline HighInsulin resistance likely, increased CVD riskImplement diet and exercise changes
3.1-4.03.1-4.0High RiskMetabolic syndrome probable, significant CVD riskComprehensive lifestyle overhaul, consider medical consultation
Above 4.0> 4.0Very High RiskSevere metabolic dysfunction, high risk of diabetes and heart diseaseUrgent medical intervention needed

Risk categories based on clinical research. Individual risk may vary based on other health factors.

A ratio below 1.0 is considered optimal and indicates excellent metabolic health. People in this range typically have efficient fat metabolism, good insulin sensitivity, and lower risk of cardiovascular disease. Ratios between 1.0 and 2.0 are acceptable but suggest room for improvement. Once your ratio exceeds 2.0, it becomes a red flag for metabolic dysfunction and increased cardiovascular risk.

Gender Differences in Ratio Interpretation

Research indicates that women and men may have slightly different optimal ranges for the triglyceride to HDL ratio. Women typically have higher HDL levels naturally, which can affect ratio calculations. Some studies suggest that women should aim for ratios below 1.5, while men should target below 2.0. However, these differences are relatively minor, and the general guidelines apply to both genders.

Health Implications of a High Ratio

A high triglyceride to HDL ratio serves as an early warning system for multiple health conditions. Most significantly, it indicates insulin resistance, a condition where your cells become less responsive to insulin's signals. This resistance forces your pancreas to produce more insulin, leading to a cascade of metabolic problems including weight gain, high blood pressure, and eventually type 2 diabetes.

Beyond diabetes risk, an elevated ratio strongly predicts cardiovascular disease. Studies have shown that people with ratios above 3.5 have a significantly higher risk of heart attacks and strokes. This increased risk stems from several factors: high triglycerides contribute to arterial plaque formation, while low HDL means less protection against this damage. Additionally, a high ratio often indicates the presence of small, dense LDL particles that penetrate arterial walls more easily than larger, fluffier LDL particles.

Metabolic Syndrome Connection

The triglyceride to HDL ratio is a key component in diagnosing metabolic syndrome, a cluster of conditions that increase your risk of heart disease, stroke, and diabetes. If your ratio exceeds 3.0, you likely meet one of the criteria for metabolic syndrome. Other components include abdominal obesity, high blood pressure, and elevated fasting glucose. Having three or more of these factors constitutes a metabolic syndrome diagnosis.

Impact on Other Body Systems

A high triglyceride to HDL ratio affects more than just your heart and metabolism. Research links elevated ratios to fatty liver disease, as excess triglycerides accumulate in liver cells. This can progress to non-alcoholic fatty liver disease (NAFLD), which affects up to 25% of adults. High ratios also correlate with increased inflammation throughout the body, contributing to conditions ranging from arthritis to certain cancers.

Common Causes of an Elevated Ratio

Understanding what drives your triglyceride to HDL ratio higher helps you target the right lifestyle changes. Diet plays a primary role, particularly the consumption of refined carbohydrates and added sugars. When you eat these foods, your liver converts excess glucose into triglycerides for storage. Simultaneously, high sugar intake can lower HDL production, creating a double negative impact on your ratio.

Physical inactivity significantly contributes to poor lipid profiles. Regular exercise helps muscles use triglycerides for energy while stimulating enzymes that help produce HDL cholesterol. Without adequate movement, triglycerides accumulate in the bloodstream while HDL levels decline. Additionally, excess body weight, particularly abdominal fat, disrupts normal lipid metabolism and promotes insulin resistance.

  • Excessive alcohol consumption, which increases triglyceride production in the liver
  • Certain medications including beta-blockers, diuretics, and corticosteroids
  • Genetic factors that affect lipid metabolism
  • Hormonal changes, including hypothyroidism and pregnancy
  • Chronic stress, which elevates cortisol and disrupts metabolic function
  • Sleep deprivation, which affects hormones regulating appetite and metabolism

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Monitoring Your Ratio

Calculating your triglyceride to HDL ratio requires a simple blood test called a lipid panel. This test measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. For the most accurate results, you should fast for 9-12 hours before the test, as recent meals can significantly affect triglyceride levels. Some healthcare providers now offer non-fasting lipid tests, but these may show higher triglyceride values.

Regular monitoring helps track your progress and adjust interventions as needed. If you have an elevated ratio, testing every 3-6 months allows you to see how lifestyle changes affect your numbers. For those with optimal ratios, annual testing usually suffices unless other risk factors are present. Understanding your complete lipid profile, including advanced markers like ApoB and ApoA1, provides even deeper insights into your cardiovascular risk.

When to Get Tested

The American Heart Association recommends that adults over 20 get their cholesterol checked every 4-6 years if they have no risk factors. However, more frequent testing is warranted if you have a family history of heart disease, diabetes, or high cholesterol. Additionally, anyone with an elevated triglyceride to HDL ratio should monitor their levels more closely, typically every 3-6 months until the ratio improves.

Strategies to Improve Your Ratio

Improving your triglyceride to HDL ratio often requires a multi-faceted approach targeting both numbers simultaneously. Dietary changes typically produce the most dramatic improvements. Reducing refined carbohydrates and added sugars can lower triglycerides by 20-50% within weeks. Focus on whole foods, including vegetables, lean proteins, and healthy fats from sources like olive oil, avocados, and nuts.

The Mediterranean diet pattern has shown particular success in improving lipid ratios. This approach emphasizes fish rich in omega-3 fatty acids, which lower triglycerides and may slightly raise HDL. Studies show that consuming fatty fish twice weekly or taking omega-3 supplements can reduce triglycerides by 15-30%. Additionally, replacing saturated fats with monounsaturated fats from olive oil and nuts helps optimize both triglyceride and HDL levels.

Exercise and Physical Activity

Regular physical activity powerfully impacts your triglyceride to HDL ratio through multiple mechanisms. Aerobic exercise helps muscles use triglycerides for fuel, directly lowering blood levels. Meanwhile, both aerobic and resistance training stimulate enzymes that produce HDL cholesterol. Aim for at least 150 minutes of moderate-intensity exercise weekly, though greater benefits occur with 300 minutes or more.

High-intensity interval training (HIIT) shows particular promise for improving lipid profiles quickly. Studies demonstrate that HIIT can increase HDL levels by 10-15% while reducing triglycerides by similar amounts. Even simple changes like taking regular walks after meals can help blunt post-meal triglyceride spikes and improve your overall ratio over time.

Lifestyle Modifications

  • Achieve and maintain a healthy weight - losing just 5-10% of body weight can significantly improve your ratio
  • Limit alcohol intake to moderate levels (one drink daily for women, two for men)
  • Quit smoking, which lowers HDL and increases cardiovascular risk
  • Manage stress through meditation, yoga, or other relaxation techniques
  • Prioritize sleep, aiming for 7-9 hours nightly
  • Stay hydrated, as dehydration can temporarily elevate triglyceride levels

Medical Interventions and Supplements

While lifestyle changes form the foundation of ratio improvement, some individuals may benefit from medical interventions. Statins, commonly prescribed for high cholesterol, primarily lower LDL but may modestly improve triglyceride to HDL ratios. Fibrates specifically target high triglycerides and can reduce levels by 30-50% while slightly increasing HDL. Niacin (vitamin B3) was once popular for raising HDL but is less commonly used due to side effects and limited cardiovascular benefit.

Several supplements show promise for improving lipid ratios. Fish oil supplements providing 2-4 grams of EPA and DHA daily can significantly lower triglycerides. Berberine, a plant compound, demonstrates effects similar to metformin in improving metabolic health and lipid profiles. Other potentially beneficial supplements include red yeast rice, plant sterols, and soluble fiber supplements like psyllium husk. Always consult with healthcare providers before starting supplements, as they can interact with medications.

Long-term Health Optimization

Maintaining an optimal triglyceride to HDL ratio requires consistent effort and regular monitoring. Success comes from making sustainable lifestyle changes rather than dramatic short-term interventions. Focus on building healthy habits gradually - start with one or two changes and add more as they become routine. This approach leads to lasting improvements in your ratio and overall health.

Remember that your triglyceride to HDL ratio is just one piece of your health puzzle. While important, it should be considered alongside other markers like blood pressure, inflammation levels, and glucose control. Regular comprehensive testing helps you understand how all these factors interact and affect your long-term disease risk. By taking a holistic approach to health optimization, you can achieve not just better numbers, but improved energy, vitality, and longevity.

References

  1. McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96(3):399-404.[PubMed][DOI]
  2. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96(8):2520-2525.[PubMed][DOI]
  3. Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014;62(2):345-349.[PubMed][DOI]
  4. Salazar MR, Carbajal HA, Espeche WG, et al. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J Intern Med. 2013;273(6):595-601.[PubMed][DOI]
  5. Bittner V, Johnson BD, Zineh I, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia. Am Heart J. 2009;157(3):548-555.[PubMed][DOI]
  6. Pacifico L, Bonci E, Andreoli G, et al. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutr Metab Cardiovasc Dis. 2014;24(7):737-743.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my triglyceride to HDL ratio at home?

You can test your triglyceride to HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing with triglycerides, HDL, and advanced markers like ApoB. The program provides regular monitoring every 3-6 months to track your progress.

What is the ideal triglyceride to HDL ratio?

The ideal triglyceride to HDL ratio is below 1.0, indicating excellent metabolic health. Ratios between 1.0-2.0 are acceptable, while anything above 2.0 suggests increased cardiovascular risk and possible insulin resistance. Ratios above 3.5 indicate significant metabolic dysfunction.

How quickly can I improve my triglyceride to HDL ratio?

With dedicated lifestyle changes, you can see improvements in your ratio within 4-8 weeks. Dietary modifications typically show the fastest results, potentially lowering triglycerides by 20-50% within weeks. Adding regular exercise and weight loss enhances these improvements over 3-6 months.

Can medications help improve my triglyceride to HDL ratio?

Yes, medications like fibrates can reduce triglycerides by 30-50% while modestly raising HDL. Statins primarily target LDL but may also improve your ratio. Fish oil supplements at therapeutic doses (2-4g daily) can significantly lower triglycerides. Always work with healthcare providers to determine the best approach.

What foods should I avoid if my ratio is high?

Avoid refined carbohydrates, added sugars, sugary drinks, processed foods, and excessive alcohol. These foods rapidly increase triglyceride production. Also limit trans fats and excessive saturated fats. Focus instead on whole foods, lean proteins, healthy fats, and high-fiber vegetables.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details